Novartis is a pharma operation at serious scale - 109,000 employees worldwide, headquartered in Basel, Switzerland, pushing medicines to over 280 million patients globally. The threat surface is massive: drug development pipelines, enterprise data management systems, and advanced technology platforms built on Snowflake and Python all need defending. Clinical data, proprietary research IP, and patient health information don't just attract opportunistic attackers - they draw nation-state actors and organized cybercrime groups targeting healthcare's uniquely high-value data.
The company operates across oncology, immunology, and cardiovascular, renal and metabolic diseases. Security work here spans the full stack of pharmaceutical enterprise environments: protecting data platforms that power drug discovery, locking down supply chain integrations, and ensuring the integrity of systems where a breach could mean compromised patient safety or regulatory catastrophe across multiple jurisdictions. The scale demands mature security engineering - not theater.
Founded in 1996, Novartis emphasizes collaboration and innovation as operational values, which in a cybersecurity context translates to cross-functional work with data engineering, clinical operations, and compliance teams. The technical environment includes modern data infrastructure alongside legacy pharmaceutical systems - a mixed estate that keeps defenders honest. If you're looking to work on security problems where the stakes are measured in human health outcomes rather than just uptime, this is that environment.
